Tack on a half-dozen zeros to your CVS receipt and you'll get a sense of the sticker shock afflicting state officials, insurers and hospitals dealing with the soaring cost of prescription drugs in ...

The researchers observed “significant” weight regain at eight, 12, and 20 weeks after discontinuation. They deduced that most patients gain back the weight they initially lost for an average of 20 ...

Some patients reluctantly shifted to save money while others have appealed for coverage of Zepbound after having experienced ...

This article delves into the approved weight loss drugs in India, their costs, and the growing market for such medications.

Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...

During the hearing, an official from Novo Nordisk will be questioned about the pricing they charge for Ozempic and ...

"My scene was supposed to be funny, and it got nothing in the f---ing Chinese Theatre," the comedian says while discussing ...

When glucagon-like peptide-1 receptor agonists (GLP-1s) like semaglutide (Wegovy) and liraglutide (Saxenda) were approved for ...

Researchers in a recent study discovered that people taking medications to help them lose weight might experience weight gain ...

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

Editors: Story has been updated from original, with material from the president of the Arizona Obesity Organization. Slug: ...